Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
18.28
+0.08 (0.44%)
At close: Dec 5, 2025, 4:00 PM EST
18.21
-0.07 (-0.38%)
After-hours: Dec 5, 2025, 7:12 PM EST
Cellebrite DI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 455.9 | 401.2 | 325.11 | 270.65 | 246.25 | 194.91 | Upgrade
|
| Revenue Growth (YoY) | 18.37% | 23.41% | 20.12% | 9.91% | 26.34% | 13.42% | Upgrade
|
| Cost of Revenue | 73.11 | 62.59 | 53.23 | 50.75 | 42.56 | 37.88 | Upgrade
|
| Gross Profit | 382.8 | 338.61 | 271.88 | 219.91 | 203.69 | 157.03 | Upgrade
|
| Selling, General & Admin | 211.79 | 183.29 | 154.26 | 138.24 | 124.33 | 91.59 | Upgrade
|
| Research & Development | 109.61 | 98.42 | 84.39 | 80.62 | 65.54 | 54.38 | Upgrade
|
| Operating Expenses | 321.4 | 281.7 | 238.64 | 218.86 | 189.87 | 145.97 | Upgrade
|
| Operating Income | 61.4 | 56.91 | 33.24 | 1.04 | 13.82 | 11.07 | Upgrade
|
| Interest & Investment Income | 374.01 | 18.22 | 10.57 | 2.03 | 0.85 | 2.71 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.35 | -1.35 | 0.21 | 0.85 | -0.19 | -0.45 | Upgrade
|
| Other Non Operating Income (Expenses) | -349.76 | -349.76 | -119.58 | 116.85 | 67.83 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | 84.3 | -275.98 | -75.56 | 120.76 | 82.31 | 13.25 | Upgrade
|
| Merger & Restructuring Charges | 0 | - | - | - | - | -1.85 | Upgrade
|
| Pretax Income | 84.3 | -275.98 | -75.56 | 120.76 | 82.31 | 11.4 | Upgrade
|
| Income Tax Expense | 7.97 | 7.02 | 5.54 | -0.05 | 10.91 | 5.62 | Upgrade
|
| Net Income | 76.33 | -283.01 | -81.1 | 120.81 | 71.4 | 5.78 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 4.69 | 0.96 | 15.13 | Upgrade
|
| Net Income to Common | 76.33 | -283.01 | -81.1 | 116.11 | 70.43 | -9.34 | Upgrade
|
| Net Income Growth | - | - | - | 69.20% | 1135.01% | - | Upgrade
|
| Shares Outstanding (Basic) | 239 | 209 | 190 | 183 | 144 | 124 | Upgrade
|
| Shares Outstanding (Diluted) | 245 | 209 | 190 | 195 | 162 | 124 | Upgrade
|
| Shares Change (YoY) | 22.84% | 10.16% | -2.68% | 20.96% | 30.59% | 1.76% | Upgrade
|
| EPS (Basic) | 0.32 | -1.35 | -0.43 | 0.64 | 0.49 | -0.08 | Upgrade
|
| EPS (Diluted) | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 | -0.08 | Upgrade
|
| EPS Growth | - | - | - | 34.09% | - | - | Upgrade
|
| Free Cash Flow | 140.25 | 123.61 | 96.83 | 13.68 | 30.94 | 60.33 | Upgrade
|
| Free Cash Flow Per Share | 0.57 | 0.59 | 0.51 | 0.07 | 0.19 | 0.49 | Upgrade
|
| Gross Margin | 83.96% | 84.40% | 83.63% | 81.25% | 82.72% | 80.57% | Upgrade
|
| Operating Margin | 13.47% | 14.18% | 10.22% | 0.39% | 5.61% | 5.68% | Upgrade
|
| Profit Margin | 16.74% | -70.54% | -24.95% | 42.90% | 28.60% | -4.79% | Upgrade
|
| Free Cash Flow Margin | 30.76% | 30.81% | 29.78% | 5.05% | 12.57% | 30.95% | Upgrade
|
| EBITDA | 72.06 | 67.51 | 43.25 | 10.24 | 20.9 | 16.95 | Upgrade
|
| EBITDA Margin | 15.80% | 16.83% | 13.30% | 3.78% | 8.49% | 8.69% | Upgrade
|
| D&A For EBITDA | 10.66 | 10.61 | 10.01 | 9.19 | 7.07 | 5.88 | Upgrade
|
| EBIT | 61.4 | 56.91 | 33.24 | 1.04 | 13.82 | 11.07 | Upgrade
|
| EBIT Margin | 13.47% | 14.18% | 10.22% | 0.39% | 5.61% | 5.68% | Upgrade
|
| Effective Tax Rate | 9.45% | - | - | - | 13.25% | 49.28% | Upgrade
|
| Revenue as Reported | 455.9 | 401.2 | 325.11 | 270.65 | 246.25 | 194.91 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.